These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Receptor ligands which bind the oxytocin receptor with selectivity and high affinity. Chemical modification of a Streptomyces silvensis derived cyclic hexapeptide. Bock MG; DiPardo RM; Williams PD; Pettibone DJ; Clineschmidt BV; Ball RG; Veber DF; Freidinger RM J Med Chem; 1990 Sep; 33(9):2321-3. PubMed ID: 2167976 [No Abstract] [Full Text] [Related]
3. Development of a novel class of cyclic hexapeptide oxytocin antagonists based on a natural product. Williams PD; Bock MG; Tung RD; Garsky VM; Perlow DS; Erb JM; Lundell GF; Gould NP; Whitter WL; Hoffman JB J Med Chem; 1992 Oct; 35(21):3905-18. PubMed ID: 1331448 [TBL] [Abstract][Full Text] [Related]
4. A structurally unique, potent, and selective oxytocin antagonist derived from Streptomyces silvensis. Pettibone DJ; Clineschmidt BV; Anderson PS; Freidinger RM; Lundell GF; Koupal LR; Schwartz CD; Williamson JM; Goetz MA; Hensens OD Endocrinology; 1989 Jul; 125(1):217-22. PubMed ID: 2544402 [TBL] [Abstract][Full Text] [Related]
5. Vasopressin receptors in human pregnant myometrium and decidua: interactions with oxytocin and vasopressin agonists and antagonists. Ivanisevic M; Behrens O; Helmer H; Demarest K; Fuchs AR Am J Obstet Gynecol; 1989 Dec; 161(6 Pt 1):1637-43. PubMed ID: 2557763 [TBL] [Abstract][Full Text] [Related]
6. Conformationally constrained o-tolylpiperazine camphorsulfonamide oxytocin antagonists. Structural modifications that provide high receptor affinity and suggest a bioactive conformation. Williams PD; Ball RG; Clineschmidt BV; Culberson JC; Erb JM; Freidinger RM; Pawluczyk JM; Perlow DS; Pettibone DJ; Veber DF Bioorg Med Chem; 1994 Sep; 2(9):971-85. PubMed ID: 7712132 [TBL] [Abstract][Full Text] [Related]
7. No requirements of cyclic conformation of antagonists in binding to vasopressin receptors. Manning M; Przybylski JP; Olma A; Klis WA; Kruszynski M; Wo NC; Pelton GH; Sawyer WH Nature; 1987 Oct 29-Nov 4; 329(6142):839-40. PubMed ID: 2959865 [TBL] [Abstract][Full Text] [Related]
8. 125I-d(CH2)5[Tyr(Me)2, Tyr(NH2)9]AVP: iodination and binding characteristics of a vasopressin receptor ligand. Elands J; Barberis C; Jard S; Lammek B; Manning M; Sawyer WH; de Kloet ER FEBS Lett; 1988 Mar; 229(2):251-5. PubMed ID: 2964381 [TBL] [Abstract][Full Text] [Related]
9. Gonadal steroids regulate oxytocin receptors but not vasopressin receptors in the brain of male and female rats. An autoradiographical study. Tribollet E; Audigier S; Dubois-Dauphin M; Dreifuss JJ Brain Res; 1990 Mar; 511(1):129-40. PubMed ID: 2158853 [TBL] [Abstract][Full Text] [Related]
10. Conformational restriction of angiotensin II: cyclic analogues having high potency. Spear KL; Brown MS; Reinhard EJ; McMahon EG; Olins GM; Palomo MA; Patton DR J Med Chem; 1990 Jul; 33(7):1935-40. PubMed ID: 2362273 [TBL] [Abstract][Full Text] [Related]
11. The synthesis of a new class of oxytocin antagonists. Wiśniewski K; Trojnar J; Riviere P; Haigh R; Yea C; Ashworth D; Melin P; Nilsson A Bioorg Med Chem Lett; 1999 Oct; 9(19):2801-4. PubMed ID: 10522694 [TBL] [Abstract][Full Text] [Related]
12. [3H]-[Thr4,Gly7]OT: a highly selective ligand for central and peripheral OT receptors. Elands J; Barberis C; Jard S Am J Physiol; 1988 Jan; 254(1 Pt 1):E31-8. PubMed ID: 2827511 [TBL] [Abstract][Full Text] [Related]
13. Design of cyclic and linear peptide antagonists of vasopressin and oxytocin: current status and future directions. Manning M; Chan WY; Sawyer WH Regul Pept; 1993 Apr; 45(1-2):279-83. PubMed ID: 8511357 [No Abstract] [Full Text] [Related]
17. Oxytocin and vasopressin binding sites in human and bovine ovaries. Fuchs AR; Behrens O; Helmer H; Vangsted A; Ivanisevic M; Grifo J; Barros C; Fields M Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 1):1961-7. PubMed ID: 2175150 [TBL] [Abstract][Full Text] [Related]
18. Oxytocin receptors in rat adenohypophysis: evidence from radioligand binding studies. Antoni FA Endocrinology; 1986 Nov; 119(5):2393-5. PubMed ID: 3021442 [TBL] [Abstract][Full Text] [Related]
19. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin. Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985 [TBL] [Abstract][Full Text] [Related]